Email us
0 items£0.00
Login

Lost your password?

Restricted Growth Association UK
  • Home
  • Who we are
    • Vision, Mission, Goals, Values
    • History
    • Who we are
  • Resources
    • Medical information: types of dwarfism
    • Information for parents
    • Resources
  • Getting Involved
    • Become a member
    • Join the committee
    • Shop
    • Donate
    • Fundraise
    • Volunteer
    • Campaigning
    • Dwarfism Awareness Month
  • News
    • Blog
    • News & Press Releases
    • Events
    • Social Media
    • Information for Media & Press
  • Home
  • Who we are
    • Vision, Mission, Goals, Values
    • History
    • Who we are
  • Resources
    • Medical information: types of dwarfism
    • Information for parents
    • Resources
  • Getting Involved
    • Become a member
    • Join the committee
    • Shop
    • Donate
    • Fundraise
    • Volunteer
    • Campaigning
    • Dwarfism Awareness Month
  • News
    • Blog
    • News & Press Releases
    • Events
    • Social Media
    • Information for Media & Press

Tag Archives: Vosoritide

Statement on the Achondroplasia Drug Trial Publication

21 June, 2019 Website AdminHomepage, News & Press ReleasesLeave a comment2

The results of the Phase 2 trial into the drug, Vosoritide, that could reduce the health complications of children with Achondroplasia was published in the New England Journal of Medicine on Tuesday 18th June 2019.Read More

My Tweets

Recent Posts

  • RGA helpline update.
  • Statement on Coronavirus from RGA medical board
  • Role models in the dwarfism community: Dr Judith Badner, MD
  • Statement on the removal of the ‘M’word from Harper Collins publications.
  • Statement on the Achondroplasia Drug Trial Publication
Copyright Restricted Growth Association UK © 2025 | Registered Charity Number: 261647 (England & Wales) | Privacy Notice | Website T&C's | Data Removal Request
Updated by Chris Banister

This website uses cookies to give you the best experience. Agree by clicking the 'Accept' button.